| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004227 Peroral Vaccine Carrier System |
| 01/01/2009 | US20090004226 Fusion proteins of mycobacterium tuberculosis |
| 01/01/2009 | US20090004225 Toxin compounds with enhanced membrane translocation characteristics |
| 01/01/2009 | US20090004224 Activatable clostridial toxins |
| 01/01/2009 | US20090004223 A vaccine to prevent diarrhea by administering an immunogenic capsulated polysaccharide based on repeating units of an O-methyl phosphoramidated heptose disaccharide without concomitantly inducing Barre-Guillain Syndrome; bioconjugating with a carrier to effect enhanced T-cell dependent immunity |
| 01/01/2009 | US20090004222 Influenza Vaccination |
| 01/01/2009 | US20090004221 Mutant Porcine Reproductive and Respiratory Syndrome Virus |
| 01/01/2009 | US20090004218 Antigen-Carbohydrate Conjugates |
| 01/01/2009 | US20090004217 for determining whether an animal is naturally-infected with Ehrlichia canis, or is either not infected or is vaccinated with an E. canis vaccine |
| 01/01/2009 | US20090004216 inducing an immunological response in an animal by administering to the animal an attenuated CSFV pestivirus, wherein the RNase activity of glycoprotein ERNS of the CSFV pestivirus is inactivated by a deletion of the second histidine of the conserved ERNS sequence RHEWNKHGWCNW |
| 01/01/2009 | US20090004215 Chimeric G protein based rabies vaccine |
| 01/01/2009 | US20090004214 Cd4+ Survivin Epitopes and Uses Thereof |
| 01/01/2009 | US20090004213 Combination therapy using active immunotherapy |
| 01/01/2009 | US20090004212 Tumour vaccines for MUC1-positive carcinomas |
| 01/01/2009 | US20090004211 Method for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using erp57 translocation |
| 01/01/2009 | US20090004210 Method for Preventing and Treating Alzheimer's Disease |
| 01/01/2009 | US20090004209 4'-O- substituted isoindoline derivatives and compositions comprising and methods of using the same |
| 01/01/2009 | US20090004208 Method for designing hypoallergenic molecules for use in allergy desensitization with lessened chance of anaphylaxis, or as vaccines against allergic reactions |
| 01/01/2009 | US20090004207 Methods and Compositions for Inhibiting Pathological Angiogenesis in the Eye |
| 01/01/2009 | US20090004206 Polynucleotides and Polypeptide Sequences Involved in the Process of Bone Remodeling |
| 01/01/2009 | US20090004205 Prospective identification and characterization of breast cancer stem cells |
| 01/01/2009 | US20090004204 Assays and methods using biomarkers |
| 01/01/2009 | US20090004203 Methods of treating measles infectious disease in mammals |
| 01/01/2009 | US20090004202 Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin |
| 01/01/2009 | US20090004201 Therapy-Enhancing Glucan |
| 01/01/2009 | US20090004200 Combination treatment of pancreatic cancer |
| 01/01/2009 | US20090004199 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 01/01/2009 | US20090004198 Human monoclonal antibody binding to human cytomegalovirus and its antigen binding portion |
| 01/01/2009 | US20090004197 Dek Protein Compositions and Methods of Using the Same |
| 01/01/2009 | US20090004196 Method of inhibiting osteoclast activity |
| 01/01/2009 | US20090004195 Somatostatin receptor antagonists and glucose control or hypoglycemia |
| 01/01/2009 | US20090004194 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity |
| 01/01/2009 | US20090004193 Diagnostics and Therapeutics for Diseases Associated With Vasoactive Intestinal Peptide Receptor 1 (Vpac1) |
| 01/01/2009 | US20090004192 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 01/01/2009 | US20090004191 Expansion of Stem/Progenitor Cells by Inhibition of Enzymatic Reactions Catalyzed by the Sir2 Family of Enzymes |
| 01/01/2009 | US20090004190 Rage Fusion Proteins And Methods Of Use |
| 01/01/2009 | US20090004189 Biological markers predictive of rheumatoid arthritis response to b-cell antagonists |
| 01/01/2009 | US20090004188 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 01/01/2009 | US20090004187 Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment (ridker) |
| 01/01/2009 | US20090004186 Effector function enhanced recombinant antibody composition |
| 01/01/2009 | US20090004185 Amino-substituted quinazoline derivatives as inhibitors of beta-catenin/tcf-4 pathway and cancer treatment agents |
| 01/01/2009 | US20090004184 Polynucleotides and polypeptides associated with the development of rheumatoid arthritis |
| 01/01/2009 | US20090004183 Compositions and Methods for Regulating the Alternative Pathway of Complement |
| 01/01/2009 | US20090004182 Methods to Treat or Prevent Viral-Associated Lymphoproliferative Disorders |
| 01/01/2009 | US20090004181 Method for Modulating Appetite |
| 01/01/2009 | US20090004180 Kifs as Modifiers of the Rho Pathway and Methods of Use |
| 01/01/2009 | US20090004179 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 01/01/2009 | US20090004178 Pharmaceutical compound for blocking the crt or erp57 translocation |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004144 Recombinant Adeno-Associated Virus Vector for Treatment of Alzheimer Disease |
| 01/01/2009 | US20090004142 A cell therapy method for the treatment of tumors |
| 01/01/2009 | US20090004135 Modified fluorinated nucleoside analogues |
| 01/01/2009 | US20090004109 Antibodies and Molecules Derived Therefrom that Bind to Steap-1 Proteins |
| 01/01/2009 | US20090004104 Methods and Compositions for Delivering Active Agents with Enhanced Pharmacological Properties |
| 01/01/2009 | US20090004102 HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 12/31/2008 | WO2009003145A1 Antibody-endostatin fusion protein and its variants |
| 12/31/2008 | WO2009003125A1 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 12/31/2008 | WO2009003082A2 Immunological compositions as cancer biomarkers and/or therapeutics |
| 12/31/2008 | WO2009003019A1 Methods of treating rsv infections and related conditions |
| 12/31/2008 | WO2009002939A2 Autophilic antibodies |
| 12/31/2008 | WO2009002562A2 Complexes of il-15 and il-15ralpha and uses thereof |
| 12/31/2008 | WO2009002542A1 Multi-day delivery of biologically active substances |
| 12/31/2008 | WO2009002521A2 Compositions of specific binding agents to hepatocyte growth factor |
| 12/31/2008 | WO2009002418A2 T-cell peptide epitopes from carcinoembryonic antigen, immunogenic analogs, and uses thereof |
| 12/31/2008 | WO2009002395A1 Vaccines for diseases of fish |
| 12/31/2008 | WO2009002380A2 Isolation of anti-desmoglein 1 antibodies by phage display of pemphigus foliaceus autoantibodies |
| 12/31/2008 | WO2009002376A1 Dna vaccine against north american spring viremia of carp virus |
| 12/31/2008 | WO2009002193A1 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof |
| 12/31/2008 | WO2009002159A2 Intradermal hpv peptide vaccination |
| 12/31/2008 | WO2009001940A1 Cancer remedy containing antibody against peptide encoded by exon-17 of periostin |
| 12/31/2008 | WO2009001904A1 Method for screening of patient to be administered with pharmaceutical agent comprising anti-cancer antibody as active ingredient |
| 12/31/2008 | WO2009001867A1 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus |
| 12/31/2008 | WO2009001840A1 Anti-prominin-1 antibody having adcc activity or cdc activity |
| 12/31/2008 | WO2009001673A1 Atp-containing immunoadjuvant |
| 12/31/2008 | WO2009001545A1 Method for detection or treatment of graft versus host disease |
| 12/31/2008 | WO2009001219A2 Immunocytokines for cancer treatment in combination with chemotherapeutic agents |
| 12/31/2008 | WO2009001217A2 Low-additive influenza vaccines |
| 12/31/2008 | WO2009001204A2 Mitogen activated protein kinase modulator |
| 12/31/2008 | WO2009000929A2 Composition and method for treatment of autoimmune disease |
| 12/31/2008 | WO2009000926A1 Combinations of sap depleting agents and anti-sap antibodies |
| 12/31/2008 | WO2009000894A1 Anti-vpac1 antibodies and their uses |
| 12/31/2008 | WO2009000826A1 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 12/31/2008 | WO2009000825A2 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 12/31/2008 | WO2009000824A2 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 12/31/2008 | WO2009000539A1 Modulation of production of retroviruses by apobec4 |
| 12/31/2008 | WO2009000459A1 Methods and compositions in the treatment of porcine circoviral infection |
| 12/31/2008 | WO2009000433A1 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
| 12/31/2008 | WO2009000406A1 Use of antibodies against the cd52 antigen for the treatment of neurological disorders, particularly transmissible spongiform encephalopathy and alzheimer's disease |
| 12/31/2008 | WO2009000217A1 Pharmaceutical compositions containing the protein nmb1796 |
| 12/31/2008 | WO2009000099A2 Methods of modifying antibodies, and modified antibodies with improved functional properties |
| 12/31/2008 | WO2009000098A2 Sequence based engineering and optimization of single chain antibodies |
| 12/31/2008 | WO2009000089A1 Immunomodulatory compositions and methods for treating disease with modified host defense peptides |
| 12/31/2008 | WO2009000077A1 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 12/31/2008 | WO2009000066A1 Vaccine against clostridium perfringens |
| 12/31/2008 | WO2008141044A3 Cysteine engineered anti-muc16 antibodies and antibody drug conjugates |
| 12/31/2008 | WO2008135419A3 Anti-il-6-agents for improving primary functioning of allogenic grafts |
| 12/31/2008 | WO2008126065A3 Polynucleotides and polypeptides involved in gestational malaria, and biological applications |
| 12/31/2008 | WO2008118017A3 Prame derived peptides and immunogenic compositions comprising these |
| 12/31/2008 | WO2008116118A3 Fully human antibodies to gram positive bacteria |